J&J Declines on Disappointing Demand for Medical Devices
Johnson & Johnson reported $25.3 billion in revenue in the second quarter, surpassing the average estimate from analysts, but disappointing demand for its medical devices overshadowed better-than-expected drug sales. Madison Muller reports on Bloomberg Television.
_1439826_640x360_2506607683825-640x360.webp&w=3840&q=75)

_1439768_640x360_2506605123792-640x360.webp&w=3840&q=75)
_1439740_640x360_2506601539819-640x360.webp&w=3840&q=75)
_1439735_640x360_2506598467909-640x360.webp&w=3840&q=75)

_1439703_640x360_2506599491662-640x360.webp&w=3840&q=75)
_1439689_640x360_2506601539506-640x360.webp&w=3840&q=75)
_1439681_640x360_2506598979679-640x360.webp&w=3840&q=75)

_1439642_640x360_2506597955882-640x360.webp&w=3840&q=75)
_1439635_640x360_2506597955718-640x360.webp&w=3840&q=75)